DEONTRANESE TAYLOR: Open Payments
NPI 1619211992 · MONTICELLO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 8 payments from 5 companies in 2025. Trend: 2023 $15 · 2024 $139 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| Novo Nordisk Inc | 1 | $18 |
Products named: CAPLYTA, Auvelity, Qelbree, INVEGA SUSTENNA, Ozempic, SPRAVATO.
Industry payments across MS — which companies pay providers there.
